Scholars Central

Conference abstractPublished 19 Feb 2021

Ethnopharmacology and Neurodegenerative Diseases: Past Achievements and Future Expectations

Authors: Jamal Ouazzani

National Center for Scientific Research CNRS, Institute for Chemistry of Natural Products ICSN, France

Clinical Pharmacology & Biopharmaceutics

Volume 10 · Issue 2 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Neurodegenerative diseases (NDs) cover various pathologies and associated disorders. The most known and disabling are Alzheimer’s disease, Parkinson’s disease and Huntington’s disease, causing motor disorders and dementia. NDs affect the ageing population and represent one of the most challenging public health issues worldwide. The situation is particularly critical due to the increasing number of patients, the cost of treatment, and the societal impact of day-to-day care and dependence. As an example, around 7 million European citizens suffer from Alzheimer's disease with a total care cost reaching 155 billion euros each year. Besides existing drugs addressing the symptoms rather than the cause, alternative natural solutions based on natural extracts or pure compounds are driving growing interest. This presentation begins with an overview of the current state of the art in the use of natural resources and the products they contain, to combat the potential causes and consequences of NDs. We will then move on to the results we have obtained in the field, by using innovative extraction technologies and controlled biotransformation processes to enhance the effectiveness and the safety of the end products. Citation: Ouazzani J (2021) Ethnopharmacology and Neurodegenerative Diseases: Past Achievements and Future Expectations. Clin Pharmacol Biopharm 10: e110 Copyright: © 2021 Ouazzani J. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Select your language of interest to view the total content in your interested language Post Your Comment Citation

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Pharmacology & Biopharmaceutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Jamal Ouazzani”